15 days with migrainous headaches per month). The majority of people with migraine can be suitably managed by treatment that addresses the acute headache. Some individuals that suffer from attacks that are more frequent or insufficiently controlled by acute therapy require prophylactic interventions. Medications such as sodium valproate, metoprolol, and topiramate have been beneficial in reducing the frequency of attacks in some people (Dodick & Silberstein, 2007; Linde, Mulleners, Chronicle, & McCrory, 2013a; Linde, Mulleners, Chronicle, & McCrory, 2013b) . However, these medications are associated with adverse effects and the dropout rates in most clinical trials suggest that these medications are not tolerated well by patients.
Therefore, low-risk interventions for prophylactic treatment of migraine require further investigation.
Acupuncture is the needling of specific points of the body and is an intervention that is often used for the relief of headache (Burke, Upchurch, Dye & Chyu, 2006) . Studies have illustrated that acupuncture in the short term effects a range of various physiological variables similar to analgesia (Endres, Diener & Molsberger, 2007) . Acupuncture as a treatment is widely used and yet, the effectiveness of this intervention in relation to episodic migraine is still debated.
| OBJECTIVE
The objectives of this updated Cochrane systematic review were to investigate whether acupuncture is more effective than no prophylactic treatment/routine care only; second, more effective than "sham"(placebo) acupuncture and third, as effective as prophylactic treatment with drugs in reducing headache frequency in patients with episodic migraine.
The primary efficacy outcome considered for this review was headache frequency at completion of treatment and at follow-up. The safety outcomes were the number of participants dropping out due to adverse effects and the number of participants that reported at least one adverse event or effect.
| METHODS
In this updated review (Linde et al., 2016) , the authors searched for randomized controlled trials (RCTs) that investigated the prophylactic effect of acupuncture and in which participants were followed up for at least 8 weeks after randomization. Interventions eligible for inclusion were any treatment involving needle insertion described as acupuncture with a treatment course of at least six sessions, minimum one per week. The controls considered for comparison included routine care, sham interventions (interventions that mimic true acupuncture but deviate in at least one aspect considered important by acupuncture theory) and prophylactic medication treatment for at least 8 weeks.
Participants included people with a diagnosis of episodic migraine with a minimum duration of 1 year. Studies were excluded if participants suffered chronic migraine or chronic daily headache, had been suffering from migraine for less than 1 year or if the duration of headache complaint was unclear.
For this update, the reviewers searched six electronic databases and trial registries for relevant trials, up to January 2016. Papers were considered for this review irrespective of language, date and publication status. Selected studies were appraised for risk of bias using the using the Cochrane Handbook for systematic reviews of interventions. Quality of evidence was assessed using GRADE.
| RESULTS
Twenty two studies with data available for 4,985 participants from Germany, Italy, Brazil, China, Sweden, United Kingdom, Denmark, and Australia were included in this updated review. Five studies previously included, were excluded from this update as the participants had migraine for less than 12 months and there were five new trials added.
All trials used parallel group designs. Fifteen studies included a sham acupuncture control, five a no-acupuncture control and five a comparator group receiving prophylactic medication treatment. There was a risk of performance and detection bias in the no acupuncture control groups and the prophylactic medication treatment groups as blinding was not possible. The overall quality of the evidence was moderate.
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wileyonlinelibrary.com/journal/nur Acupuncture was associated with a small statistically significant reduction in after treatment headache frequency (50% reduction in 100 participants) compared to sham acupuncture (41% reduction in 100 participants), 53%, and 42%, respectively at follow up. The number of participants that reported an adverse effect and the number dropping out due to adverse effects did not differ between the groups.
Acupuncture as an additional intervention to routine care or treatment of migraine attacks was associated with a moderate reduction of headache frequency (41% reduction in 100 participants) compared to no prophylactic treatment/routine care only (17% reduction in 100 participants). The pooled analyses of three trials (730 participants) that compared acupuncture to evidence based prophylactic medication treatment found that acupuncture reduced headache frequency significantly. However, the significance was not sustained at followup. At 3 months in the acupuncture intervention group headache frequency halved in 57% of participants. In the prophylactic medication group, there was a 46% reduction noted. Side effects and dropout rates were reported less in the acupuncture intervention group compared to the participants receiving drug therapy.
| CONCLUSIONS
The key point for nurses is that the evidence suggests that acupuncture seems to be a beneficial prophylactic intervention to reduce the frequency of episodic migraine. The findings approximate that if the average migraine suffer reported 6 migraine days per month (baseline) prior to treatment, this would be reduced to 4 days in the sham and prophylactic medication group, 5 days in the no prophylactic treatment/routine care only, and three and a half in the acupuncture group. As migraine is a chronic condition, nurses caring for this population should support further research to examine the long-term effects associated with acupuncture as this research is currently limited.
| IMPLICATIONS FOR PRACTICE
This review highlights that acupuncture could be considered as a treatment option for individuals that suffer from migraine attacks that are more frequent or insufficiently controlled by acute therapy. This prophylactic intervention may be suitable for people that would like to avoid pharmacological prophylaxis or have experienced adverse effects from these medications.
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